Cary Pfeffer
Partner · Third Rock Ventures
Cary Pfeffer, a Partner at Third Rock Ventures, invests in early-to-mid-stage life sciences and biotechnology companies, focusing on novel drug discovery, gene and cell therapies, immunology, oncology, and neuroscience[1][11]. His recorded investments include Series A and B rounds typically ranging from
2M to $81M, with a personal sweet spot around
.5M and an investment range of
